nach oben

Erschienen in:

23.06.2021 | Case Study

Inoperable CASTLE of the thyroid gland treated with radical radiotherapy with complete remission

verfasst von: Petra Kovářová, MD, Radovan Vojtíšek, MD, PhD, Michal Krčma, MD, PhD, Prof. Ondřej Daum, MD, PhD, Prof. Jan Baxa, MD, PhD, Emília Sukovská, MD, Prof. Jindřich Fínek, MD, PhD, MHA

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Carcinoma showing thymus-like elements (CASTLE) is an extremely rare malignant tumor of the thyroid gland and soft tissues of the neck with favorable prognosis. Histological features of the CASTLE are similar to thymic carcinoma, and it is assumed that it arises from the ectopic thymic tissue or the remnants of branchial pouches. The optimal treatment strategy is still uncertain because of the rarity of the tumor. The mainstay of treatment is surgery. The role of other modalities is unclear. We present a case report of a patient with locally advanced CASTLE of the thyroid gland who was not suitable for surgery and underwent radical radiotherapy with subsequent achievement of complete remission. We also present a literature review.

Wong EHC, Tetter N, Tzankov A, Muller L (2018) CASTLE tumor of the parotid: first documented case, literature review, and genetic analysis of the cancer. Head Neck 40(1):E1–E4CrossRef

Zhang G, Liu X, Huang W et al (2015) Carcinoma showing thymus-like elements of the thyroid gland: report of three cases including one case with breast cancer history. Pathol Oncol Res 21(1):45–51CrossRef

Chan JK, Rosai J (1991) Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 22(4):349–367CrossRef

Miyauchi A, Kuma K, Matsuzuka F et al (1985) Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid. World J Surg 9(1):128–135CrossRef

Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134(5):536–538CrossRef

Gao R, Jia X, Ji T et al (2018) Management and prognostic factors for thyroid carcinoma showing thymus-like elements (CASTLE): a case series study. Front Oncol 8:477CrossRef

Luo CM, Hsueh C, Chen TM (2005) Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor‑a new case report and review of literature. Head Neck 27(10):927–933CrossRef

Cheuk W, Chan JKC, Dorfman DM, Giordano T (2004) Carcinoma showing thymus-like differentiation. In: Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 96–97

Patil VR, Patel K, Muzumdar G (2016) Carcinoma showing thymus like differentiation (CASTLE)—A rare thyroid neoplasm. Thyroid Res Pract 13:71–73CrossRef

10.

Ito Y, Miyauchi A, Nakamura Y et al (2007) Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol 127(2):230–236CrossRef

11.

Steger CM, von Frankenberg M, Kahlert C et al (2009) CASTLE tumour of the neck: a rare location of a malignant tumour of the thymus. BMJ Case Rep. https://doi.org/10.1136/bcr.06.2009.1937CrossRefPubMedPubMedCentral

12.

Ge W, Yao YZ, Chen G, Ding YT (2016) Clinical analysis of 82 cases of carcinoma showing thymus-like differentiation of the thyroid. Oncol Lett 11(2):1321–1326CrossRef

13.

Wu B, Sun T, Gu Y et al (2016) CT and MR imaging of thyroid carcinoma showing thymus-like differentiation (CASTLE): a report of ten cases. Br J Radiol 89(1060):20150726CrossRef

14.

Liu Z, Teng XY, Sun DX et al (2013) Clinical analysis of thyroid carcinoma showing thymus-like differentiation: report of 8 cases. Int Surg 98(2):95–100CrossRef

15.

Kusada N, Hara Y, Kobayashi S et al (2005) A case of aggressive carcinoma showing thymus-like differentiation with distant metastases. Thyroid 15(12):1383–1388CrossRef

16.

Luo CM, Hsueh C, Chen TM (2005) Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor—A new case report and review of literature. Head Neck 27(10):927–933CrossRef

17.

Bayer-Garner IB, Kozovska ME, Schwartz MR, Reed JA (2004) Carcinoma with thymus-like differentiation arising in the dermis of the head and neck. J Cutan Pathol 31(9):625–629CrossRef

18.

Häfner M, Roeder F, Sterzing F et al (2015) Postoperative radiotherapy of patients with thymic epithelial tumors (TET). Strahlenther Onkol 191:133–140CrossRef

19.

Fung ACH, Tsang JS, Lang BHH (2019) Thyroid carcinoma showing thymus-like differentiation (CASTLE) with tracheal invasion: a case report. Am J Case Rep 10(20):1845–1851CrossRef

20.

Kong F, Ying H, Zhai R et al (2016) Clinical outcome of intensity modulated radiotherapy for carcinoma showing thymus-like differentiation. Oncotarget 7(49):81899–81905CrossRef

21.

Chow SM, Chan JK, Tse LL et al (2007) Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease. Eur J Surg Oncol 33(1):83–85CrossRef

22.

Kropf J, Castaneira G, Luc LT et al (2019) A case of thymic carcinoma with bone and cerebral metastases treated with stereotactic radiosurgery and chemotherapy. Am J Case Rep 20:1669–1674CrossRef

23.

Tsutsui H, Hoshi M, Kubota M et al (2013) Management of thyroid carcinoma showing thymus-like differentiation (CASTLE) invading the trachea. Surg Today 43(11):1261–1268CrossRef

24.

NCCN NCCN guidelines version 1.2021. Thymomas and thymic carcinomas. https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf. Accessed: 20 Feb 2021

25.

Roka S, Kornek G, Schüller J et al (2004) Carcinoma showing thymic-like elements—A rare malignancy of the thyroid gland. Br J Surg 91(2):142–145CrossRef

26.

Hanamura T, Ito K, Uehara T et al (2015) Chemosensitivity in carcinoma showing thymus-like differentiation: a case report and review of the literature. Thyroid 25(8):969–972CrossRef

27.

Kelly RJ, Petrini I, Rajan A et al (2011) Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol 29(36):4820–4827CrossRef

28.

Weissferdt A, Fujimoto J, Kalhor N et al (2017) Expression of PD‑1 and PD-L1 in thymic epithelial neoplasms. Mod Pathol 30(6):826–833CrossRef

Titel: Inoperable CASTLE of the thyroid gland treated with radical radiotherapy with complete remission
verfasst von: Petra Kovářová, MD
Radovan Vojtíšek, MD, PhD
Michal Krčma, MD, PhD
Prof. Ondřej Daum, MD, PhD
Prof. Jan Baxa, MD, PhD
Emília Sukovská, MD
Prof. Jindřich Fínek, MD, PhD, MHA
Publikationsdatum: 23.06.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 9/2021
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-021-01800-6

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Inoperable CASTLE of the thyroid gland treated with radical radiotherapy with complete remission

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2021

Prädiktion der pathologischen Komplettremission beim Ösophaguskarzinom nach neoadjuvanter Radiochemotherapie mittels FDG-PET/CT und diffusionsgewichteter MRT

Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial

Motion-compensated FDG PET/CT for oesophageal cancer

Konditionierung mit Ganzkörperbestrahlung oder Chemotherapie bei ALL im Kindesalter

Incidental axillary dose delivery to axillary lymph node levels I–III by different techniques of whole-breast irradiation: a systematic literature review

Strahlentherapie mit 24-Gy-Einzeldosis und 3-Fraktionen-SBRT zur Behandlung von oligometastasierten Malignomen?

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie